COVID-19 and blood cancer registry
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/04/032865
- Lead Sponsor
- Tata Memorial Hospital Mumbai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients of ages above 18 years who have a current or previously diagnosed hematologic cancer within the past five years.
2)Diagnosed to have concomitant COVID-19 infection after 1stMarch 2020 through RT-PCR COVID-19 or antigen-based testing.
Exclusion Criteria
1)Patients who are not on any treatment for hematologic cancer and are in remission formore than five years
2)Patients/family members unwilling to giving informed consent
3)Definitive diagnosis of hematologic cancer not made ante-mortem or post mortem
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method COVID-19 infection related mortality in patients with hematological malignanciesTimepoint: At Day 30 and 3 month.
- Secondary Outcome Measures
Name Time Method To analyse the characteristics pertaining to hematologic cancers and the impact of diagnosis of SARS-CoV-2 infection on the treatment of hematologic cancers.Timepoint: At day 30 and 3 month